Nanukayami Fever

Nanukayami fever is a specific form of leptospirosis caused by infection with Leptospira interrogans serovar Hebdomadis. The name "nanukayami" derives from Japanese and translates to "seven-day fever," reflecting the characteristic duration of the febrile episode observed in affected individuals. While leptospirosis as a broader disease entity is well recognized in veterinary medicine, the Hebdomadis serovar represents a distinct strain with particular epidemiological and clinical features that differentiate it from other leptospiral infections.

Leptospira organisms are thin, motile, helically coiled spirochetes that thrive in warm, moist environments. The Hebdomadis serovar was first identified in Japan in association with febrile illness among agricultural workers and was subsequently recognized as a cause of disease in domestic animals including dogs. The organism maintains itself in nature through chronic renal carriage in reservoir hosts, primarily rodents and small mammals, which shed the bacteria in their urine and contaminate soil, water sources, and vegetation.

In dogs, nanukayami fever can range from a subclinical infection with minimal outward signs to a severe, life-threatening illness involving multi-organ dysfunction. The clinical presentation depends on factors including the infecting dose, the route of exposure, the dog's immune status, and the timeliness of treatment. Like other forms of leptospirosis, nanukayami fever carries zoonotic significance, meaning it can be transmitted from infected animals to humans, making accurate diagnosis and appropriate biosecurity measures important considerations in case management.

The global distribution of the Hebdomadis serovar extends across Asia, Europe, and other regions where suitable environmental conditions and reservoir host populations exist. While historically most recognized in Japan and Southeast Asia, improved diagnostic capabilities have led to increased identification of this serovar in canine leptospirosis cases in other parts of the world. Understanding this condition as a distinct clinical entity within the leptospirosis spectrum helps veterinarians anticipate its behavior and optimize treatment protocols.

Nanukayami fever is caused by infection with the spirochete Leptospira interrogans serovar Hebdomadis. The organism is a gram-negative, obligate aerobic bacterium with a characteristic helical morphology that enables it to penetrate mucous membranes and abraded skin with remarkable efficiency. Once inside the host, the spirochetes disseminate rapidly through the bloodstream, establishing infection in target organs, particularly the kidneys and liver.

Transmission to dogs occurs through several routes, all involving contact with the Leptospira organism in the environment or from infected animals. Direct contact with urine from infected reservoir hosts, primarily rodents such as field mice and voles, is a significant source of exposure. Dogs may encounter contaminated urine while exploring rodent habitats, investigating burrows, or traversing areas where wildlife activity is concentrated. The bacteria can survive for extended periods in moist soil and standing water, creating persistent environmental reservoirs of infection.

Indirect transmission through contaminated water is perhaps the most common route of canine infection. Puddles, ponds, streams, irrigation channels, and flooded areas can all harbor viable Leptospira organisms shed by infected wildlife. Dogs that drink from, wade through, or swim in contaminated water sources are at risk of infection through mucous membrane exposure or through penetration of the organism through waterlogged or abraded skin. Warm, stagnant water in tropical and subtropical environments provides particularly favorable conditions for bacterial survival.

Direct contact with infected animals, either through bite wounds, contact with reproductive fluids, or exposure to tissues during hunting or scavenging, represents an additional transmission route. Venereal transmission between dogs has been documented with some Leptospira serovars. Transplacental transmission from an infected dam to puppies in utero can result in fetal infection, abortion, or the birth of congenitally infected neonates.

Seasonal patterns of transmission reflect the environmental requirements of the organism. Cases tend to increase during warm, wet seasons when rainfall creates standing water, flooding disperses contaminated material across wider areas, and increased rodent activity enhances environmental contamination. Agricultural activities such as rice planting and harvesting, which bring humans and animals into close contact with flooded fields and rodent habitats, have historically been associated with outbreaks of nanukayami fever in endemic regions.

The clinical presentation of nanukayami fever in dogs mirrors the general spectrum of canine leptospirosis but may exhibit certain features associated with the Hebdomadis serovar. Following an incubation period of approximately four to twelve days after exposure, the disease typically begins with an acute febrile phase characterized by a sudden onset of high fever, often reaching 40 to 41 degrees Celsius. The fever characteristically persists for approximately seven days, consistent with the condition's common name, though individual variation in fever duration is observed.

During the acute leptospiremic phase, dogs commonly display nonspecific signs of systemic illness including marked lethargy, anorexia, reluctance to move, and generalized muscle pain manifesting as a stiff gait or reluctance to be handled. Vomiting and diarrhea may develop as the gastrointestinal tract is affected by the bacteremia and associated inflammatory response. Conjunctival injection, presenting as reddening of the scleral and conjunctival vessels, is a frequently observed finding that can serve as an early clinical clue.

As the disease progresses beyond the initial bacteremic phase, organ-specific manifestations emerge depending on the primary sites of bacterial localization. Renal involvement is common and may present as increased thirst and urination in early stages, progressing to oliguria or anuria as acute kidney injury develops. Dogs with significant renal compromise may develop uremia, presenting with oral ulceration, uremic breath odor, and progressive deterioration in mentation. Hepatic involvement manifests as icterus (jaundice) of the mucous membranes, skin, and sclera, along with hepatomegaly and elevated liver enzyme activities on blood work.

Hemorrhagic manifestations can develop in moderate to severe cases. Petechial and ecchymotic hemorrhages on the mucous membranes, skin, and serosal surfaces reflect vascular endothelial damage caused by the spirochetes and associated inflammatory mediators. Epistaxis, hematemesis, melena, and hematuria may occur in dogs with significant coagulopathy. Pulmonary hemorrhage, though less commonly recognized in dogs than in human leptospirosis, can present as dyspnea, coughing, and hemoptysis.

Subclinical and mild infections also occur, particularly in dogs with some degree of pre-existing immunity from prior exposure or vaccination against related serovars. These dogs may exhibit only transient fever, mild lethargy, and decreased appetite before recovering spontaneously. However, even subclinically infected dogs can develop chronic renal carriage, shedding Leptospira organisms in their urine for weeks to months and serving as potential sources of infection for other animals and humans.

Diagnosing nanukayami fever requires a combination of clinical assessment, serological testing, and direct detection methods. Because the clinical signs of leptospirosis overlap significantly with numerous other canine diseases, laboratory confirmation is essential for definitive diagnosis. The microscopic agglutination test (MAT) remains the reference standard serological method and is particularly useful for identifying the specific infecting serovar, including Hebdomadis.

The MAT works by detecting agglutinating antibodies in the patient's serum against panels of live Leptospira serovars maintained in laboratory culture. A positive result is indicated by significant antibody titers against one or more serovars, with the highest titer often, though not always, corresponding to the infecting serovar. Acute and convalescent paired titers collected two to four weeks apart demonstrating a fourfold or greater rise in titer provide the strongest serological evidence of active infection. Single high titers must be interpreted cautiously, as they may reflect prior exposure or vaccination rather than current infection.

Polymerase chain reaction (PCR) testing has become an increasingly important diagnostic tool for leptospirosis. PCR can detect Leptospira DNA in blood during the early leptospiremic phase and in urine during the renal shedding phase. The advantage of PCR over serology is its ability to confirm infection before antibody responses have developed, enabling earlier diagnosis. However, PCR sensitivity depends on appropriate sample timing, and negative results do not definitively exclude infection, particularly if samples are collected during the transition between bacteremia and renal shedding.

Routine clinicopathologic findings support the clinical suspicion of leptospirosis and help assess disease severity. A complete blood count may reveal leukocytosis with a left shift, thrombocytopenia, and mild to moderate anemia. Serum biochemistry panels typically show azotemia reflecting renal compromise, elevated hepatocellular and cholestatic liver enzymes, hyperbilirubinemia in icteric cases, and electrolyte derangements. Urinalysis may reveal isosthenuria, glucosuria, proteinuria, and the presence of granular casts, reflecting tubular damage.

Darkfield microscopy of blood or urine can occasionally visualize live spirochetes, but this technique has low sensitivity and poor specificity, as artifacts can mimic the appearance of Leptospira. Culture of the organism from blood or urine provides definitive identification but requires specialized media, prolonged incubation periods of several weeks, and is not routinely performed in clinical practice. Immunohistochemistry and silver staining of tissue biopsies can identify Leptospira in renal and hepatic tissue, though these are more commonly employed in postmortem diagnostic evaluation.

Treatment of nanukayami fever follows the established protocols for canine leptospirosis and is divided into two phases: elimination of the acute bacteremia and eradication of the renal carrier state. Prompt initiation of antibiotic therapy is critical for improving outcomes, and treatment should begin as soon as leptospirosis is clinically suspected, without waiting for laboratory confirmation. Delays in starting antibiotics allow continued spirochetal multiplication and progressive organ damage.

The first-line antibiotic for the acute leptospiremic phase is intravenous penicillin G or ampicillin. These beta-lactam antibiotics are highly effective at clearing Leptospira from the bloodstream and halting active tissue invasion. Intravenous administration is preferred in hospitalized patients because it ensures reliable drug delivery in animals that may be vomiting or have compromised gastrointestinal absorption. Treatment with penicillin-class antibiotics is typically continued for the duration of hospitalization or until the patient is stable enough for oral medication.

Following resolution of the acute phase, a course of doxycycline is administered to eliminate the renal carrier state. Doxycycline is the antibiotic of choice for clearing Leptospira from the renal tubules, where the organisms can persist despite apparent clinical recovery. A standard course of doxycycline at 5 mg/kg orally twice daily for two weeks is recommended to achieve reliable clearance of renal shedding. This step is essential both for the individual patient's complete recovery and for reducing the zoonotic and environmental contamination risk posed by chronic shedding.

Supportive care is a critical component of treatment, particularly in dogs with significant organ compromise. Intravenous fluid therapy is the cornerstone of supportive management, addressing dehydration, maintaining renal perfusion, and correcting electrolyte imbalances. Dogs with oliguric or anuric renal failure may require more aggressive fluid management, diuretic therapy, or in severe cases, referral for hemodialysis. Antiemetic medications control vomiting and improve patient comfort, while gastroprotectant drugs help manage gastrointestinal mucosal damage.

Additional supportive measures are tailored to the specific complications present in each case. Dogs with coagulopathy and active hemorrhage may require fresh frozen plasma transfusions to provide clotting factors. Severe anemia may necessitate packed red blood cell transfusions. Hepatoprotective therapies and nutritional support help optimize hepatic recovery in dogs with significant liver involvement. Throughout the treatment course, close monitoring of renal and hepatic parameters, hydration status, and overall clinical trajectory guides ongoing therapeutic adjustments.

The prognosis for dogs with nanukayami fever depends primarily on the severity of organ involvement at the time of diagnosis and the promptness of treatment initiation. Dogs with mild to moderate disease that receive appropriate antibiotic and supportive therapy within the first few days of illness generally carry a good to excellent prognosis, with reported survival rates exceeding 80 percent in many clinical series of canine leptospirosis.

Renal function is one of the most important prognostic indicators. Dogs that maintain adequate urine production throughout the course of illness tend to recover well, with renal parameters gradually returning to normal over days to weeks following treatment. Dogs that develop oliguric or anuric renal failure carry a significantly more guarded prognosis, though aggressive fluid therapy and, when available, hemodialysis can support recovery even in some severely affected patients. Some dogs that survive acute renal injury may retain mild chronic kidney disease requiring ongoing monitoring and dietary management.

Hepatic involvement, while often dramatic in its clinical appearance with pronounced jaundice, generally carries a favorable prognosis for recovery. The liver has substantial regenerative capacity, and hepatic function typically normalizes within weeks to months following successful treatment of the infection. Dogs with concurrent severe hepatic and renal compromise face the most challenging recovery course and carry a more guarded overall prognosis.

The recovery period following acute leptospirosis requires ongoing veterinary monitoring. Serial blood work to track renal and hepatic parameters ensures that organ recovery is progressing appropriately and allows early detection of any secondary complications. Urinalysis should be performed periodically to monitor renal concentrating ability and to assess for ongoing proteinuria, which may indicate residual renal tubular damage. Completion of the full course of doxycycline is essential to prevent relapse and eliminate the carrier state.

Long-term outcomes for most dogs that survive the acute phase of nanukayami fever are positive. The majority of dogs return to their normal activity levels and quality of life within several weeks of completing treatment. Owners should be counseled that reinfection is possible, as immunity following natural infection may be serovar-specific and may not provide broad protection against other Leptospira strains. Implementation of preventive measures and consideration of vaccination are important components of post-recovery management.

Prevention of nanukayami fever involves a multifaceted approach combining environmental management, exposure reduction, and vaccination where appropriate. Limiting a dog's contact with potential sources of Leptospira contamination is a fundamental preventive strategy. Preventing access to stagnant water bodies, flooded areas, and locations with heavy wildlife activity reduces the risk of environmental exposure. Providing clean, fresh drinking water and discouraging dogs from drinking from puddles, ponds, or streams is a simple but effective measure.

Rodent control in and around the home environment, kennels, and outdoor areas frequented by dogs helps reduce environmental contamination with Leptospira organisms. Eliminating food sources that attract rodents, sealing entry points to buildings, maintaining short vegetation around structures, and employing professional pest management services all contribute to reducing the reservoir host population and thereby the risk of canine exposure.

Vaccination is an important preventive tool for canine leptospirosis, though its application to nanukayami fever specifically requires some consideration. Currently available canine leptospirosis vaccines typically contain two to four serovars, most commonly Canicola, Icterohaemorrhagiae, Grippotyphosa, and Pomona. The Hebdomadis serovar is not included in most commercially available vaccines, which means that standard leptospirosis vaccination may not provide direct protection against nanukayami fever. However, some degree of cross-protective immunity between related serovars may offer partial protection.

Despite the limitations regarding serovar-specific coverage, leptospirosis vaccination remains strongly recommended for dogs at risk of exposure to any Leptospira serovar. The vaccine is administered as an initial series of two doses given two to four weeks apart, followed by annual boosters. Dogs in endemic areas or with high-risk lifestyles, including hunting dogs, farm dogs, and dogs with access to wildlife habitats or standing water, should be prioritized for vaccination. Veterinarians in regions where the Hebdomadis serovar is prevalent should stay informed about developments in vaccine formulations that may expand serovar coverage.

Biosecurity practices are particularly important given the zoonotic nature of leptospirosis. Owners of dogs diagnosed with or suspected of having nanukayami fever should practice careful hygiene when handling the animal, avoiding contact with urine, and disinfecting contaminated surfaces. Leptospira organisms are susceptible to common disinfectants, desiccation, and ultraviolet light, but can persist in moist environments for extended periods. Informing household members and coordinating with public health professionals when zoonotic exposure is suspected are responsible components of case management.

Nanukayami fever holds significant zoonotic importance because the causative Leptospira interrogans serovar Hebdomadis can infect humans through the same routes by which dogs acquire the infection. The disease was originally described in humans, particularly among agricultural workers in Japan who developed febrile illness after working in rice paddies and other flooded agricultural settings. Understanding the zoonotic potential of this condition is essential for protecting both animal and human health.

Humans can acquire nanukayami fever through direct contact with the urine of infected animals, including dogs in the renal shedding phase. The organism enters the body through mucous membranes, conjunctivae, or through abraded or waterlogged skin. Dog owners caring for a pet with active leptospirosis face occupational exposure risk, particularly during the period before diagnosis when routine hygiene precautions may not be in place. Veterinary staff handling infected animals and their body fluids are also at risk and should employ appropriate personal protective equipment.

In humans, nanukayami fever typically presents as an acute febrile illness with headache, myalgia, conjunctival suffusion, and malaise. The disease is generally considered milder than infections caused by more virulent serovars such as Icterohaemorrhagiae, which can produce severe Weil's disease with hepatorenal failure. Nevertheless, complications including meningitis, uveitis, and renal dysfunction can occur in human cases, and the disease should not be dismissed as inconsequential.

When a dog in the household is diagnosed with leptospirosis, several protective measures should be implemented to minimize human exposure risk. Wearing gloves when cleaning up urine, promptly disinfecting areas where the dog has urinated, washing hands thoroughly after handling the animal, and preventing the dog from urinating in areas where children play or where barefoot contact might occur are practical steps that substantially reduce transmission risk.

Veterinary professionals play a crucial role in the public health response to canine leptospirosis cases. Informing owners about the zoonotic risk, recommending that household members who develop febrile illness seek medical attention and mention the pet's diagnosis, and in some jurisdictions reporting confirmed cases to public health authorities are all important responsibilities. The One Health framework, which recognizes the interconnection of human, animal, and environmental health, provides the conceptual foundation for addressing zoonotic diseases like nanukayami fever through coordinated interdisciplinary efforts.

While nanukayami fever can affect dogs of any breed, age, or sex, certain populations face elevated risk based on their lifestyle, geographic location, and environmental exposure patterns. Understanding which dogs are most likely to encounter the Hebdomadis serovar helps veterinarians and owners implement targeted preventive strategies and maintain appropriate diagnostic vigilance.

Working and sporting dogs represent one of the highest-risk populations for leptospiral infections including nanukayami fever. Hunting dogs that range through fields, wetlands, and forested areas have frequent contact with wildlife habitats and contaminated water sources. Herding dogs on farms and ranches encounter rodent populations and agricultural water sources that may harbor Leptospira. Search and rescue dogs, police dogs, and military working dogs may be deployed in environments with high exposure risk, including disaster zones with flooding and disrupted sanitation infrastructure.

Dogs living in rural and agricultural settings face increased exposure through proximity to livestock operations, grain storage facilities that attract rodents, and irrigation systems that can distribute contaminated water. In regions where rice cultivation or other wet agriculture is practiced, the environmental conditions that favor Leptospira survival are particularly pronounced. Dogs in tropical and subtropical climates face year-round risk due to consistently warm temperatures and frequent rainfall that maintain favorable conditions for the organism.

Urban and suburban dogs are not immune to leptospirosis, and increasing urbanization has created new patterns of exposure risk. Urban wildlife including rats, raccoons, and opossums can serve as reservoir hosts, contaminating parks, greenways, and residential yards with Leptospira-laden urine. Dogs that frequent dog parks, hiking trails, or any outdoor area with standing water or wildlife activity may encounter the organism. Urban flooding events can dramatically increase exposure risk by dispersing contaminated water across wide areas.

Age and immune status influence disease susceptibility and severity. Young dogs experiencing their first exposure may develop more severe clinical disease due to the absence of any pre-existing immunity. Immunosuppressed dogs, whether due to concurrent illness, medication, or other factors, may be more susceptible to infection and may experience more severe disease progression. Conversely, dogs in endemic areas that have experienced prior subclinical exposure may have some degree of immunity that modulates the severity of subsequent infections, though serovar-specific immunity means that protection against one strain does not guarantee protection against others.

Owners should seek veterinary evaluation for any dog displaying signs consistent with leptospiral infection, particularly when environmental risk factors for exposure are present. The nonspecific early signs of nanukayami fever, including fever, lethargy, and decreased appetite, overlap with many other conditions, but the potential for rapid deterioration and the zoonotic implications make prompt professional assessment essential for both animal and human health.

Immediate veterinary attention is warranted when a dog develops sudden onset of high fever accompanied by muscle stiffness, reluctance to move, and visible discomfort. The combination of fever with vomiting, diarrhea, or both should prompt urgent evaluation, as these signs may indicate the onset of organ involvement. Any dog that has recently had contact with standing water, flooded areas, or wildlife and subsequently develops illness should be evaluated with leptospirosis included in the differential diagnosis.

The development of jaundice, manifesting as yellowing of the gums, whites of the eyes, inner ear flaps, or skin, is a significant clinical finding that demands immediate veterinary intervention. Icterus indicates hepatic involvement and may accompany or precede renal compromise, representing a progression of disease that requires aggressive treatment. Similarly, changes in urination patterns, whether increased volume and frequency or decreased to absent urine production, suggest renal involvement and should be evaluated urgently.

Any evidence of hemorrhage in a febrile dog should be treated as an emergency. Spontaneous bruising, bleeding from the gums or nose, blood in the urine or stool, or small red spots on the mucous membranes may indicate coagulopathy associated with severe leptospirosis. These hemorrhagic manifestations carry serious prognostic implications and require immediate diagnostic evaluation and treatment.

Owners of dogs diagnosed with nanukayami fever or any form of leptospirosis should monitor their own health and that of other household members, including other pets. Any person who develops fever, headache, muscle pain, or conjunctival redness after contact with an infected dog should seek medical attention promptly and inform their healthcare provider about the animal's diagnosis. Early recognition and treatment of human leptospirosis significantly improves outcomes, and the connection between the pet's illness and potential human exposure should not be overlooked.